The tasigna lawsuit involves patients who took the leukemia drug Tasigna and later developed serious artery damage. Tasigna is the brand name for nilotinib. Novartis makes the drug. Plaintiffs claim the company knew about a heart-related risk. However, they say Novartis failed to warn American patients and doctors. These cases are now grouped in a federal court in Florida. This page explains the litigation in plain terms. It also outlines who may qualify and what to expect. Always consult a licensed attorney about your own situation.
Case Timeline
Last checked: September 03, 2026
What Is the Tasigna Lawsuit About?
Tasigna is a tyrosine kinase inhibitor. The FDA approved it in 2007. Doctors prescribe it for Philadelphia chromosome-positive chronic myeloid leukemia, often called CML. The drug slows cancer growth. However, lawsuits allege it can also harm the arteries. Many patients took Tasigna for years before any strong warning appeared in the United States.
The core injury involves atherosclerosis. That means hardening and narrowing of the arteries. Restricted blood flow can follow. As a result, some patients developed peripheral arterial disease. Others reported coronary artery disease, heart attacks, strokes, or limb amputations. In the most tragic cases, patients died. These are severe and life-changing conditions.
The tasigna lawsuit centers on a failure-to-warn claim. In 2013, Health Canada alerted the public to atherosclerosis risks. Novartis then updated its Canadian product label. However, plaintiffs say the company did not add the same clear warning in the United States for a long time. They argue Novartis concealed the danger. As a result, patients say they lost the chance to switch drugs or monitor their health.
MDL Case Status and Key Facts
| MDL Detail | Current Data |
|---|---|
| MDL Number | MDL-3006 |
| Pending Cases | 36 |
| Presiding Judge | Roy B. Dalton, Jr |
| Federal District | FLM |
| Data Source | U.S. Judicial Panel on Multidistrict Litigation |
| Last Updated | August 03, 2026 |
Similar federal cases were combined into one proceeding. This is called a multidistrict litigation, or MDL. An MDL keeps pretrial work efficient. It does not merge the cases into a single claim. Each plaintiff keeps their own case. The table below summarizes the key facts.
| Detail | Information |
|---|---|
| MDL Number | MDL-3006 |
| Case Name | In re: Tasigna (Nilotinib) Products Liability Litigation |
| Presiding Judge | Roy B. Dalton, Jr. |
| Federal District | Middle District of Florida (FLM) |
| Centralized | August 10, 2021 |
| Approximate Pending Cases | 36 |
| Bellwether Trials | None publicly scheduled as of July 2026 |
The MDL sits before Senior District Judge Roy B. Dalton, Jr. He manages the case in Orlando. The docket has stayed relatively small. Roughly 36 cases remain pending. For example, some cases were filed and later resolved or dismissed. New cases can still be added over time.
No bellwether trial dates have been announced publicly. Bellwether trials are test cases. They help both sides gauge how juries react. Their outcomes often guide settlement talks. Until then, the tasigna lawsuit remains in the pretrial phase. The parties continue to exchange evidence and expert reports.
Who Qualifies for the Tasigna Lawsuit?
Eligibility depends on your medical history. Typically, a claimant took Tasigna to treat CML. The exposure usually spans months or years. After treatment, a qualifying injury appeared. This often means atherosclerosis or peripheral arterial disease. Coronary artery disease, stroke, and amputation may also qualify.
Timing matters in these claims. Many strong cases involve use before the U.S. warning was strengthened. However, later use may still count in some situations. An attorney can review the exact dates. For example, prescription records help pin down your treatment window. Medical records then link the drug to your injury.
Evidence is the backbone of any claim. You typically need proof you took Tasigna. Pharmacy and prescription records work well. You also need a documented diagnosis. Imaging, cardiology reports, and hospital records help. In most cases, a lawyer gathers these for you. If a loved one died, family members may still have rights.
How to File a Tasigna Lawsuit Claim
The process starts with a free case review. Most drug injury lawyers work on contingency. That means no upfront fee. They only get paid if you recover money. First, contact a licensed attorney who handles MDL cases. Then share your treatment and diagnosis details.
Next, your lawyer investigates your file. They confirm your Tasigna use and injury. If your case fits, they file it in the MDL. You will likely complete a Plaintiff Fact Sheet. This standardized form collects your medical and drug history. It is a required step in most drug MDLs. Accuracy here is very important.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Act quickly because deadlines apply. Every state has a statute of limitations. This legal clock limits how long you can wait to sue. The window varies widely by state. As a result, waiting too long can bar your claim entirely. Some states also use a “discovery rule.” That may extend the deadline until you connected the drug to your harm. An attorney can confirm your specific deadline.
Settlement Updates and What to Expect From a Tasigna Lawsuit
No global settlement exists in this MDL yet. As of July 2026, there have been no announced jury verdicts. There is no master settlement framework either. The tasigna lawsuit remains in active pretrial litigation. Any figures you see online are speculative. Be cautious about promises of a fixed payout.
Settlement values, if they come, will vary. Several factors typically influence any award. These include injury severity and medical costs. Lost wages and long-term care needs also matter. Age and prognosis play a role too. As a result, no two cases are worth the same amount. You may qualify for compensation, but nothing is guaranteed.
Timelines in MDLs can be long. Bellwether results often shape negotiations. For context, a separate matter shows Novartis has faced federal scrutiny. In an unrelated case, the company paid $390 million to resolve kickback allegations tied to Tasigna promotion. That case was about fraud, not personal injury. However, it shows the drug’s contested history. Your own tasigna lawsuit would be judged on its own facts.
State-by-State Considerations
State law shapes each claim inside the MDL. Federal judges apply the law of the state where your case originated. Tort reform rules differ sharply across states. Some cap non-economic damages. Others limit punitive damages. As a result, two similar injuries may lead to different outcomes.
Plaintiffs in this litigation come from across the country. States like Florida, California, Texas, New York, and Pennsylvania often see notable drug injury filings. Statutes of limitations also vary by state. For example, some states allow only two years, while others allow more. Review your state guide and speak with a local attorney to understand your rights.
Frequently Asked Questions
What injuries are linked to the tasigna lawsuit?
The main claims involve atherosclerosis and peripheral arterial disease. Some patients also report coronary artery disease, stroke, or amputation. Any diagnosis should be confirmed by your own doctors and reviewed by an attorney.
Is there a settlement in MDL-3006 yet?
No, there is no global settlement or announced verdict as of July 2026. The cases remain in the pretrial stage. Any potential compensation would depend on future developments and your individual facts.
How do I know if I still have time to file?
Deadlines depend on your state’s statute of limitations. These windows vary and can pass quickly. Contact a licensed attorney promptly to confirm whether your claim is still timely.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- U.S. Judicial Panel on Multidistrict Litigation (JPML)
- U.S. Department of Justice
- FDA Safety Alerts & Recalls
- Centers for Disease Control and Prevention
- U.S. Environmental Protection Agency
Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Pennsylvania Tort Reform Guide
- Florida Tort Reform Guide
- Georgia Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.